Literature DB >> 20797352

Survival and apoptosis rates after vitrification in cryotop devices of in vitro-produced calf and cow blastocysts at different developmental stages.

Roser Morató1, Dolors Izquierdo, Maria Teresa Paramio, Teresa Mogas.   

Abstract

Two experiments were designed to determine the ability of in vitro-cultured blastocysts at different stages of development to survive the vitrification procedure using cryotop devices. Day 7 and Day 8 embryos were classified as non-expanded, expanded or hatching and/or hatched blastocysts. In the first experiment, we examined the survival rate of vitrified-warmed blastocysts after 3 h incubation in synthetic oviducal fluid (SOF) medium. In the second experiment, vitrified-warmed blastocysts were evaluated using the terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labelling (TUNEL) technique to detect nuclei with damaged DNA. In both experiments, results for cow and calf blastocysts were compared. No differences in survival rates were observed after vitrification of Day 8 expanded (52.4%) and hatched (50%) cow blastocysts or Day 8 expanded (54.5%) and hatched (59.4%) calf blastocysts. When embryos were vitrified on Day 7, survival rates of 78.4% and 66.7% were observed after warming expanded and hatched cow blastocysts, respectively, compared with rates of 80% and 76.9%, respectively, for calf blastocysts. Lowest survival rates were recorded for non-expanded blastocysts (26%-54%) compared with the other developmental stages, particularly those vitrified at Day 8 (</=40%). The DNA integrity index obtained after vitrification-warming was comparable to that for control fresh blastocysts, regardless of the length of embryo culture, the developmental stage of the embryo or the source of the oocytes. Our findings suggest that the cryotop vitrification method is particularly useful for the cryopreservation of blastocysts presenting with a high degree of expansion (expanded or hatched blastocysts), particularly when vitrification is performed after 7 days of in vitro embryo culture.

Entities:  

Mesh:

Year:  2010        PMID: 20797352     DOI: 10.1071/RD10013

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  6 in total

1.  Transcriptomic difference in bovine blastocysts following vitrification and slow freezing at morula stage.

Authors:  Alisha Gupta; Jaswant Singh; Isabelle Dufort; Claude Robert; Fernanda Caminha Faustino Dias; Muhammad Anzar
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

2.  The role of cGMP as a mediator of lipolysis in bovine oocytes and its effects on embryo development and cryopreservation.

Authors:  Kátia R L Schwarz; Fernanda C de Castro; Letícia Schefer; Ramon C Botigelli; Daniela M Paschoal; Hugo Fernandes; Cláudia L V Leal
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

3.  Inhibition of Apoptotic Pathways Improves DNA Integrity but Not Developmental Competence of Domestic Cat Immature Vitrified Oocytes.

Authors:  Martina Colombo; Jennifer Zahmel; Stefanie Jänsch; Katarina Jewgenow; Gaia Cecilia Luvoni
Journal:  Front Vet Sci       Date:  2020-10-16

4.  A Shorter Equilibration Period Improves Post-Warming Outcomes after Vitrification and in Straw Dilution of In Vitro-Produced Bovine Embryos.

Authors:  Iris Martínez-Rodero; Tania García-Martínez; Erika Alina Ordóñez-León; Meritxell Vendrell-Flotats; Carlos Olegario Hidalgo; Joseba Esmoris; Xabier Mendibil; Sabino Azcarate; Manel López-Béjar; Marc Yeste; Teresa Mogas
Journal:  Biology (Basel)       Date:  2021-02-10

5.  Exopolysaccharide ID1 Improves Post-Warming Outcomes after Vitrification of In Vitro-Produced Bovine Embryos.

Authors:  Erika Alina Ordóñez-León; Iris Martínez-Rodero; Tania García-Martínez; Manel López-Béjar; Marc Yeste; Elena Mercade; Teresa Mogas
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

6.  Recent progress in cryopreservation of bovine oocytes.

Authors:  In-Sul Hwang; Shinichi Hochi
Journal:  Biomed Res Int       Date:  2014-03-16       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.